Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

ConditionCervical Intraepithelial Neoplasia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano

About this trial

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Eligibility criteria

Qualifiers

Treatment of HPV-related disease

Disqualifiers

Previous HPV vaccination

Trial design

Treatments tested in this trial

Not listed

Trial groups

600 Participants

are grouped into 1 trial group

Sponsors and collaborators

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Lead sponsor

Source ClinicalTrials.gov